lamotrix 50mg tableta
medochemie ltd., limassol array - 9440 lamotrigin - tableta - 50mg - lamotrigin
paracetamol/caffeine pharmaclan 500mg/65mg potahovaná tableta
pharmaclan s.r.o., praha array - 1064 paracetamol; 223 kofein - potahovaná tableta - 500mg/65mg - paracetamol, kombinace kromĚ psycholeptik
dopegyt 250mg tableta
egis pharmaceuticals plc, budapešť array - 11523 seskvihydrÁt methyldopy - tableta - 250mg - methyldopa (levotoČivÁ)
sarclisa
sanofi winthrop industrie - isatuximab - mnohočetný myelom - antineoplastická činidla - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.